Noticias de GH_US
Noticias del mercado
Últimas noticias sobre GH_US — 414 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Price-action only: Guardant Health Inc. (GH) movements set the tone for institutional models. How (GH) Movements Inform Risk Allocation Models
Natera said on Oct. 9 that the FDA granted Breakthrough Device designation after reviewing data across 12 cancer types; authorization remains pending.
GRAIL, Inc. (NASDAQ:GRAL) traded at around $133 on October 7, down 3.19% on the day, though still 93.00% higher over twelve months. Guardant Health, Inc. (NASDAQ:GH) traded near $168 over the same session, up 161.55% across the year. Both sell blood tests that look for cancer, and one of them has seven times the revenue […]
Guardant Health announced on Oct. 8 that Guardant360 CDx's European CE mark for camizestrant was the company's 31st companion diagnostic approval.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Página 3 de 21